|
|
|
| () | |
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Page 1 of 2
-
Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom
on May 05, 2008 by Bespoke Investment Group
-
FDA's "Risky Business" for Pharma & Biotech
on Apr 29, 2008 by Mike Huckman
-
Schering Beat the Street and Plows Through Vytorin Firestorm
on Apr 23, 2008 by Mike Huckman
-
Stocks with Biggest Gains Last Week; Furthest Above 50-DMAs
on Apr 07, 2008 by Bespoke Investment Group
-
Best and Worst Performers Since the 3/10 Bottom
on Apr 03, 2008 by Bespoke Investment Group
-
Vertex's Telaprevir May Become a Multi-Billion Dollar Drug
on Apr 02, 2008 by A. Reza Saadat
-
Vytorin Battle Pits Merck and SGP against Pfizer
on Apr 02, 2008 by Mike Huckman
-
Insider Buying in Biotech Land
on Apr 01, 2008 by Dan Rosenblum
-
Healthcare Stocks Have Been Anything but Defensive
on Mar 13, 2008 by Bespoke Investment Group
-
Earnings Preview: Vertex Pharmaceuticals
on Feb 10, 2008 by theflyonthewall.com
-
Hepatitis C Developments Drag Biotechs Down
on Jan 24, 2008 by H.S. Ayoub
-
2007 Biotech Performance Review
on Jan 21, 2008 by A. Reza Saadat
-
Pharma, Biotech Present Great Investment Opportunities in 2008
on Jan 09, 2008 by A. Reza Saadat
-
Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile
on Dec 13, 2007 by Don Dion
-
Retail Investors Should Grasp Opportunity In Vertex Pharmaceuticals
on Oct 23, 2007 by A. Reza Saadat
-
Thursday's Options Report: Citigroup, Bank of America, Google, SunTrust, Vertex Pharma
on Oct 18, 2007 by Andrew Wilkinson
-
PBE: Large Biotech Meets Small Biotech
on Oct 04, 2007 by Don Dion
-
Russell 1,000 Stocks Furthest From Their 50-Day Moving Averages
on Aug 27, 2007 by Bespoke Investment Group
-
Vertex Pharmaceutical's Hepatitis Drug Proves Effective, But Path To Market Unclear
on May 31, 2007 by A. Reza Saadat
-
Organic Growth Stocks That Should Lead the Pack
on Mar 04, 2007 by SA Editor Eli Hoffmann
-
Vertex Optimistic on Hepatitis C Drug
on Feb 12, 2007 by Travis Johnson
-
Biotech Indices Mixed as AMEX Gains, Nasdaq Slips
on Jan 09, 2007 by H.S. Ayoub
-
Vertex Hepititis C Drug: A Potential Blockbuster
on Jan 04, 2007 by H.S. Ayoub
-
Investors Infected With Vertex Fever Should Seek Healthier Stocks -- Barron's
on Nov 26, 2006 by SA Editor Eli Hoffmann
-
Vertex May Win Race for Hepatitis C Drug
on Nov 06, 2006 by SA Editor Miriam Metzinger
-
Searching for Shorts
on Sep 19, 2006 by Chad Brand
-
Earnings Season Thoughts on Google, MEMC, Akamai, Intuitive Surgical and Vertex
on Jul 27, 2006 by Travis Johnson
-
Chart: Biotech Stocks - Annual Earnings Growth
on Jul 27, 2006 by Robert Zenilman
-
Chart: Biotech Stocks - Quarterly Earnings Growth
on Jul 20, 2006 by Robert Zenilman
-
Chart: Biotech Stocks - Annual Revenue Growth (Last 12 Months Reported)
on Jul 13, 2006 by Robert Zenilman
-
Chart: Biotech Stocks - Quarterly Revenue Growth
on Jul 06, 2006 by Robert Zenilman
-
Vertex Pharaceuticals' Deal with J&J Makes Good Sense (VRTX)
on Jul 02, 2006 by Travis Johnson
-
Chart: Biotech Stocks - Change in Cash-On-Hand
on Jun 14, 2006 by Robert Zenilman
-
Chart: Biotech Stocks - Normalized Net Income Per Employee
on Jun 09, 2006
-
Chart: Biotech Stocks - Revenue Per Employee
on May 31, 2006 by SA Editors
-
Chart: Biotech Stocks - Normalized Net Profit Margins
on May 23, 2006 by SA Editors
-
Chart: Biotech Stocks - SG&A Margin (MRQ)
on May 11, 2006 by SA Editors
-
Chart: Biotech Stocks - Gross Profit Margins
on May 04, 2006 by SA Editors
-
Biotech Bloodletting: CV Therapeutics and Vertex Pharmaceuticals (CVTX, VRTX)
on Apr 26, 2006 by Travis Johnson
-
Chart: Biotechnology Companies - Annual Net Income Growth
on Apr 25, 2006 by SA Editors
-
Chart: Biotech Stocks - Annual Revenue Growth
on Apr 11, 2006 by SA Editors
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »